Dr. Reddy’s Laboratories has completed a definitive transaction with Johnson & Johnson to acquire Stugeron Forte and Stugeron Plus across 18 markets in the APAC and EMEA regions, with India and Vietnam as key markets.Stugeron Cinnarizine, an antihistamine indicated for the treatment of vestibular disturbances and vertigo. With Stugeron already holding first position in the Cinnarizine represented pharmaceutical market (RPM) and ranked second in the anti-vertigo extended represented pharmaceutical market (eR ...